It is a remarkable proof for the concept of IOB: working closely hand in hand, our molecular and clinical researchers have developed a library of 230 adeno associated viral vectors (AAVs), each with a different synthetic promoter. A number of these AAVs specifically target expression to neuronal and glial cell types in the mouse and non-human primate retina in vivo, and in the human retina in vitro.